Texas Capital Bancshares Inc
Change company Symbol lookup
Select an option...
TCBI Texas Capital Bancshares Inc
IBB iShares Nasdaq Biotechnology ETF
NEP Nextera Energy Partners LP
FRAN Francesca's Holdings Corp
CDTI CDTi Advanced Materials Inc
UBER Uber Technologies Inc
MTX Minerals Technologies Inc
PRGS Progress Software Corp
CODA Coda Octopus Group Inc
WAB Westinghouse Air Brake Technologies Corp
Go

Financials : Banks | Small Cap Growth
Company profile

Texas Capital Bancshares, Inc. is a bank holding and a financial holding company. The Company is the parent of Texas Capital Bank, National Association (the Bank). It offers a range of loan, deposit account and other financial products and services to its customers. It offers a range of products and services for its business customers, including commercial loans for general corporate purposes, including financing for working capital, internal growth, acquisitions and financing for business insurance premiums; medium- and long-term tax-exempt loans for municipalities and other governmental and tax-exempt entities; wealth management and trust services, and letters of credit. It also provides banking services for its individual customers, including personal wealth management and trust services; certificates of deposit; interest-bearing and non-interest-bearing checking accounts; traditional money market and savings accounts; loans, both secured and unsecured, and Internet banking.

Postmarket

Last Trade
Delayed
$38.75
0.23 (0.60%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$38.52
Day's Change
1.21 (3.24%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
38.84
Day's Low
37.15
Volume
(Heavy Day)
Volume:
464,851

10-day average volume:
341,646
464,851

Smart Inhalers Market Worth $445.40 Million at 41.1% CAGR; Increasing Prevalence of Asthma & COPD to Boost Growth: Fortune Business Insights(TM)

10:28 am ET August 27, 2020 (Globe Newswire) Print

The report mentions that the smart inhalers market size was USD 28.62 million in 2019 and is projected to reach USD 445.40 million by 2027, exhibiting a CAGR of 41.1% during the forecast period.

The global market is set to gain impetus from the rising utilization of digital technology in the field of healthcare devices. It is aiding in increasing the efficiency of drug delivery devices and is, in turn, speeding up the treatment procedures. This information is published by Fortune Business Insights(TM) in a recent report, titled, "Smart Inhalers Market Size, Share & Industry Analysis, By Product (Dry Powder Inhaler (DPI) - Based Smart Inhalers, Metered Dose Inhaler (MDI) - Based Smart Inhalers), By Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel) and Regional Forecast, 2020-2027."

This Report Answers the Following Questions:

-- What are the market trends, growth drivers, hindrances, challenges, and opportunities?

-- Which key strategies will the prominent companies adopt to survive in the market?

-- Which region is set to dominate the market in the coming years?

-- Which segment is anticipated to lead in terms of share in the near future?

-- How will the market be affected during the forecast period?

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/smart-inhalers-market-102705

Drivers & Restraints-

Rising Prevalence of Acute Respiratory Ailments to Spur Growth

The Global Burden of Disease conducted a study in 2015. It states that between 1990 to 2015, the cases of chronic obstructive pulmonary disease (COPD) upsurged by approximately 14.7%. It proves that the rising incidence of chronic respiratory diseases, such as COPD and asthma worldwide is likely to propel the smart inhalation devices market growth during the forthcoming period.

In addition to that, patients are nowadays inclining gradually towards connected drug delivery devices from the manual ones because of the former's possession of superior properties. Coupled with this, the increasing focus of the masses on preventive care would contribute to the market growth. However, manual inhalers are still considered to be substitute products. It may obstruct growth.

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit: https://www.fortunebusinessinsights.com/smart-inhalers-market-102705

Competitive Landscape-

Key Players Focus on Launching Technologically Advanced Products to Intensify Competition

The market houses a large number of active companies. Though the market is still at the nascent stage of development, these companies are emphasizing on research and development activities, as well as introducing new technologies to augment sales. Below are two of the key industry developments:

-- January 2016: Qualcomm Life and Novartis collaborated to develop the former's digital inhaler for patients affected by COPD. The device is called Breezhaler. It would aid both companies in strengthening their positions in the market.

-- April 2016: The 3M Company introduced the 3M Intelligent Control Inhaler. It is a fully-integrated device that is intuitive and provides accurate doses to patients. It also delivers on-screen instructions via an app for feedback and usage to the healthcare provider and the patient, respectively.

Quick Buy - Smart Inhalers Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102705

Regional Analysis-

Rising Digitization in Healthcare to Favor Growth in North America

Geographically, the market is fragmented into Asia Pacific, Europe, North America, and the rest of the world. Amongst these, North America procured USD 20.04 million revenue in 2019. This growth is attributable to the major contribution of the U.S. The country is experiencing flexible regulatory scenario and favorable government policies. Additionally, its healthcare sector is going through tremendous digitalization.

Asia Pacific is set to exhibit a lucrative growth owing to the rising number of vendors tapping the unexplored economies in this region. Coupled with this, the increasing expenditure on the development of healthcare infrastructure and IT in the emerging countries would affect the market in this region positively.

Fortune Business Insights(TM) lists out the names of all the companies operating in the global Smart Inhalers Market. They are as follows:

-- Adherium

-- Propeller Health

-- Cohero Health Inc.

-- GlaxoSmithKline

-- AstraZeneca plc

-- Novartis AG

-- 3M Company

-- Teva Pharmaceuticals

-- Vectura Group

-- Others

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/smart-inhalers-market-102705

Smart Inhalers Market Segmentations:

By Product

? Dry Powder Inhaler (DPI)- based Inhalers

? Metered Dose Inhaler (MDI)- based Inhalers

By Disease indication

? Asthma

? Chronic Obstructive Pulmonary Disease (COPD)

By Distribution Channel

? Hospital Pharmacies

? Retail Pharmacies

? Online Channel

By Geography

? North America (U.S. and Canada)

? Europe (U.K., Germany, France, Italy, Spain, and Rest of Europe)

? Asia-Pacific (Japan, China, India, Australia, and Rest of Asia- Pacific)

? Rest of the world (Row)

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/smart-inhalers-market-102705

Have a Look at Related Reports:

Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share & Industry Analysis, By Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027

Anti-Fungal Drugs Market Share & Industry Analysis, By Drug Type (Echinocandins, Azoles, Polyenes, and Allylamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis, and Others), By Route of Administration (Oral, Topical, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Drug Stores, and Others), and Regional Forecast, 2020-2027

Anti-Inflammatory Drugs Market Share & Industry Analysis, By Drug Class (Anti-inflammatory Biologics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids), By Application (Autoimmune Inflammatory Diseases (Rheumatoid Arthritis Psoriasis), Respiratory Diseases), By Route of Administration (Oral, Injection, Inhalation, and Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), and Regional Forecast, 2020-2027

Nebulizer Market Share & COVID-19 Impact Analysis, By Type (Jet Nebulizer, Ultrasonic Nebulizer, and Mesh Nebulizer) By Modality (Portable, and Table-top) By End User (Hospitals, Clinics, and Homecare Settings), and Regional Forecast, 2020-2027

Cystic Fibrosis Market Share & Covid-19 Impact Analysis, By Drug Class (Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), Bronchodilators, Mucolytic, Pancreatic Enzyme Supplement, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies, and Hospital Pharmacies), and Regional Forecast, 2020-2027

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights(TM) Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Fortune Business Insights(TM)

LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/smart-inhalers-market-9851

https://ml.globenewswire.com/media/05408ba1-26b1-4fdd-8f48-1af4df373348/small/fbi-logo-tm-png.png

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.